Andrew Robbins Salary and Compensation - Cogent Biosciences, Inc. CEO Salary 2025

In fiscal year 2025, Andrew Robbins, Chief Executive Officer of Cogent Biosciences, Inc. (COGT), received total compensation of $27.8 million.

Andrew Robbins's compensation breakdown includes: base salary of $725K, bonus of $22K, stock awards valued at $13.0 million, option awards of $13.4 million, non-equity incentive compensation of $562K, and other compensation of $14K.

Compared to fiscal year 2024, Andrew Robbins's total compensation increased 465% from $4.9 million to $27.8 million.

Cogent Biosciences, Inc. (COGT) Executive Pay 2025

Cogent Biosciences, Inc.'s top 5 named executive officers received combined total compensation of $63.5 million in fiscal year 2025.

The named executive officers disclosed in Cogent Biosciences, Inc.'s 2025 proxy statement are:Andrew Robbins (Chief Executive Officer) with total compensation of $27.8 million, Jessica Sachs (Chief Medical Officer) with total compensation of $9.2 million, John Robinson (Chief Scientific Officer) with total compensation of $9.2 million, Cole Pinnow (Chief Commercial Officer) with total compensation of $8.8 million, and John Green (Chief Financial Officer) with total compensation of $8.5 million.